Dark

RGC
Regencell Bioscience Holdings Limited
stock NASDAQ

At Close

Jul 3, 2025 3:59:30 PM EDT

19.42USD+87.452%(+9.06)18,796,057

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jul 3, 2025 9:28:30 AM EDT

11.20USD+8.108%(+0.84)86,351

After-hours

Jul 3, 2025 4:58:30 PM EDT

19.55USD+0.669%(+0.13)40,883

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

11.28B

Headquarters

TN, USA

Industry

Drug Manufacturers-Specialty & Generic

Next Earnings

Jul 7, 2025 (1d)

Last Split

Jun 16, 202538for1

RDI MCS CNK AMC

RGC Stats

Avg. Vol. 10 Day

3,242,754

Avg. Vol. 30 Day

2,081,774

Employees

26,000

Market Cap

11,279,291,991

Shares Out.

494,488,908

On/Off Exchange

57%/43%

6 Month Beta

-0.64

1 Year Beta

-0.45

2 Year Beta

-0.38

3 Year Beta

-0.18

52 Week Low

0.08

52 Week High

83.60

SMA50

15.85

SMA200

4.16

1 Week

+33.86%

1 Month

+26.38%

3 Month

+2,896.19%

6 Month

+17,595.89%

1 Year

+23,784.82%

2 Year

+3,840.23%

5 Year

+8,155.52%

Profile

we are an early-stage bioscience company that focuses on research, development and commercialization of tcm for the treatment of neurocognitive disorders and degeneration, specifically attention deficit hyperactivity disorder ("adhd"), autism spectrum disorder ("asd") in infectious diseases such as covid-19. our goal is to improve the lives of adhd, asd and covid patients, their families and caregivers and become a market leader for the best tcm treatment globally.

RGC Stock Summary

Regencell Bioscience Holdings Limited (NASDAQ:RGC) stock price today is $19.42, and today's volume is 18,796,057. RGC is up 87.452% today. The 30 day average volume is 2,081,774. RGC market cap is 11.28B with 494,488,908 shares outstanding.